Pharmaceutical OOS Investigation Decision Support Tool
Purpose: This interactive decision matrix provides a structured, risk-based approach for evaluating Out-of-Specification (OOS) test results during pharmaceutical manufacturing investigations. The tool aligns with current FDA and MHRA regulatory requirements for OOS investigations and supports objective decision-making through weighted scoring criteria. Key Benefits: Standardizes investigation decisions, provides audit trail documentation, ensures regulatory compliance, reduces subjective bias, and […]
